- Pasha Healthcare
- Posts
- Overtime 🚫 Blocked, Fraud Fines 💸, and an AI Shake-Up
Overtime 🚫 Blocked, Fraud Fines 💸, and an AI Shake-Up
From halted overtime rules to a $23M billing scandal and California’s AI crackdown, healthcare compliance is under siege. Add the DOJ’s merger showdown to the mix, and it’s clear: employers need a game plan to navigate the storm.
Blocked 🚫 Overtime Rule: Impact on Healthcare Employers
A federal judge has struck down the DOL's proposed salary threshold increase for overtime exemptions, resetting it to approximately $35K. The decision halts the planned increases to $44K and $59K, with implications for healthcare employers navigating compensation and compliance.

Key Points
The ruling eliminates the automatic three-year adjustments and reverts the salary threshold to $35K.
Healthcare employers who adjusted salaries or reclassified employees may need to reconsider those changes to maintain compliance and employee morale.
Increased scrutiny of exemption classifications by employees and regulators is likely, particularly for healthcare roles with overlapping administrative and clinical duties.
Why It Matters
The decision places healthcare employers in a complex position, balancing compliance with operational efficiency. Given the unique demands of healthcare staffing, exemption classifications and overtime policies need careful alignment to avoid litigation or morale issues. Additionally, state-level wage laws may further complicate compliance for multi-state organizations.
Takeaway
Healthcare employers should immediately review employee classifications and wage policies to ensure compliance with the reverted salary threshold and the FLSA duties test. Prepare for increased audits and consider consulting legal counsel for tailored strategies. Maintaining transparency with employees about compensation plans will be key to avoiding confusion and preserving trust.
UCHealth's $23M Lesson: Billing Practices Under the Microscope 🔬
UCHealth has agreed to pay $23 million to settle allegations of fraudulent billing practices related to emergency department visits, highlighting significant scrutiny over billing accuracy and compliance in healthcare operations.

Key Points
UCHealth allegedly billed Medicare and TRICARE for higher levels of service than provided in emergency departments.
The settlement resolves allegations without determining liability for the period between November 1, 2017, and March 31, 2021.
The investigation was initiated by a whistleblower, Timothy Sanders, under the False Claims Act.
UCHealth has agreed to pay $23 million to resolve the allegations.
Why It Matters
The $23 million settlement highlights the federal government’s growing scrutiny of billing practices in the healthcare sector, particularly for emergency department operations. This case underscores that even prominent healthcare systems like UCHealth are not exempt from accountability when it comes to compliance with the False Claims Act. The alleged use of automated coding practices that inflated billing claims for emergency department visits represents a significant compliance risk for other providers. With whistleblower cases on the rise and regulatory bodies emphasizing billing accuracy, this settlement serves as a warning to healthcare entities to ensure their billing systems meet federal standards. For legal and compliance officers, the case is a stark reminder of the reputational and financial repercussions of noncompliance.
Takeaway
Healthcare organizations should immediately review and audit their billing practices, particularly in high-risk areas like emergency department operations. Special attention should be given to automated coding systems to ensure compliance with federal requirements and to avoid vulnerabilities that could lead to whistleblower actions or regulatory enforcement. Proactively addressing these issues will safeguard financial integrity and reduce exposure to significant penalties and reputational damage.
AI ✨ Meets Healthcare 🩺 : California's SB 1120 Takes the Stage
California's SB 1120 introduces regulations for the use of artificial intelligence in health plan utilization review and management activities, effective January 2025, mandating transparency, accountability, and oversight to ensure AI systems are used ethically and effectively in healthcare decision-making processes.

Key Points
SB 1120 requires health plans to disclose AI system details to the Department of Managed Health Care by January 2025.
The regulation mandates health plans to provide annual reports on AI system performance and impact.
SB 1120 enforces the establishment of AI system oversight committees to ensure compliance.
Health plans must ensure AI systems do not discriminate based on race, ethnicity, or other protected characteristics.
Why It Matters
California’s SB 1120 introduces critical regulations on the use of AI in healthcare utilization review, emphasizing individualized decision-making, human oversight, transparency, and non-discrimination. This law sets a precedent for balancing technological innovation with patient safety and compliance, signaling broader implications for healthcare providers and insurers nationwide. Organizations that fail to meet these standards risk penalties, reputational harm, and heightened regulatory scrutiny.
Takeaway
Healthcare entities must ensure AI tools comply with SB 1120 by auditing their systems, reinforcing human oversight, and adopting transparent policies to safeguard ethical practices and legal compliance.
DOJ Blocks UnitedHealth's $33B Merger: A Legal Showdown
The Department of Justice has filed for an injunction to prevent UnitedHealth from proceeding with its proposed $33 billion merger, setting the stage for a significant legal confrontation.

Key Points
The DOJ's injunction aims 🎯 to halt UnitedHealth's $33 billion merger proposal.
The legal action represents a significant challenge to UnitedHealth's expansion plans.
The merger's potential impact on competition in the healthcare market is a central concern.
The case is set to be a major legal confrontation in the healthcare industry.
Why It Matters
The DOJ’s effort to block UnitedHealth’s $3.3 billion merger with Amedisys highlights increasing antitrust scrutiny in healthcare, potentially reshaping future consolidation efforts. This case could set a precedent for curbing market dominance, influencing everything from competitive strategies to pricing and patient care. If successful, it signals a stronger regulatory stance prioritizing consumer protection over market consolidation.
Takeaway
Healthcare organizations should closely follow this case, as its outcome may redefine merger strategies and antitrust considerations, shaping the landscape for future consolidation and competitive positioning.